Neuren Pharmaceuticals Ltd (NEU) Company Profile

Neuren Pharmaceuticals Ltd Company Snapshot

Neuren Pharmaceuticals Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neuren Pharmaceuticals Ltd with three other companies in this sector in AUSTRALIA : BTC Health Ltd (2020 sales of 169,604.00 Australian Dollars [US$131,373.56 ] ), BARD1 Life Sciences Ltd (98,385.00 Australian Dollars [US$76,208.04 ] ), and Botanix Pharmaceuticals Ltd (180,578.00 Australian Dollars [US$139,873.91 ] of which 100% was Research & Development).

Sales Analysis. During the year ended December of 2020, sales at Neuren Pharmaceuticals Ltd were A$147,000.00 (US$113.86 thousand). This is a sharp decrease of 62.2% versus 2019, when the company's sales were A$389,000.00 .

Neuren Pharmaceuticals Ltd

Stock Data:

Recent Stock Performance:

Current Price (4/30/2021): 1.30
(Figures in Australian Dollars)

1 Week	-0.4%	13 Weeks	-10.1%

4 Weeks	0.0%	52 Weeks	-14.8%

Neuren Pharmaceuticals Ltd Key Data:

Ticker:	NEU	Country:	Australia

Exchanges:	ASX	Major Industry:	Commercial Services & Supplies

		Sub Industry:	Commercial Physical Research

2020 Sales	147,000 (Year Ending Jan 2021).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	152,302,500

Fiscal Yr Ends:	December	Shares Outstanding:	117,608,108

Share Type:	Ordinary	Closely Held Shares:	39,922,343

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.